Advertisement
Mihael H. Polymeropoulos, M.D., President and Chief Executive Officer,will host a conference call to discuss the results and other corporatedevelopments at 10:30 AM ET on Thursday, February 14, 2008. Alsoparticipating on the call will be Steven A. Shallcross, Senior Vice Presidentand CFO. To participate in the conference call, dial the appropriate numberbelow shortly before the 10:30 AM start time and ask for the VandaPharmaceuticals conference call hosted by Dr. Polymeropoulos.
Advertisement
The conference call will be broadcast simultaneously and archived on theCompany's Web site, www.vandapharma.com. Investors should go to the Web siteat least 15 minutes early to register, download, and install any necessaryaudio software.
A replay of the call will be available on Thursday, February 14, 2008,beginning at 12:30 PM ET and will be accessible until Thursday, February 21,2008, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for domesticcallers and 1-617-801-6888 for international callers. The access number is16341258.
About Vanda Pharmaceuticals Inc.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on thedevelopment and commercialization of clinical-stage product candidates forcentral nervous system disorders. The company has three product candidates.Vanda's lead product candidate, iloperidone, is a compound for the treatmentof schizophrenia and bipolar disorder, for which Vanda has recently submittedan NDA to the FDA. Vanda's second product candidate, VEC-162, is a compoundfor the treatment of sleep and mood disorders, which is currently in Phase IIIfor sleep disorders. Vanda's third product candidate, VSF-173, is a compoundfor the treatment of excessive sleepiness in Phase II. For more on VandaPharmaceuticals Inc., please visit http://www.vandapharma.com.The teleconference dial-in numbers are as follows: Domestic callers 1-866-578-5747 International callers 1-617-213-8054
SOURCE Vanda Pharmaceuticals Inc.
